Definium Therapeutics, Inc. (DFTX)
18.47
+0.68
(+3.82%)
USD |
NASDAQ |
Mar 25, 16:00
18.72
+0.25
(+1.35%)
After-Hours: 20:00
Definium Therapeutics Total Assets (Quarterly) : 440.10M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 96.11M |
| RxSight, Inc. | 314.34M |
| Plus Therapeutics, Inc. | 16.32M |
| Viridian Therapeutics, Inc. | 899.42M |
| Nutriband, Inc. | 8.419M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 107.77M |
| Shareholders Equity (Quarterly) | 332.33M |
| Debt to Equity Ratio | 0.1221 |
| Current Ratio | 6.287 |
| Net Debt Paydown Yield | -0.25% |